⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for matuzumab

Every month we try and update this database with for matuzumab cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Safety Study of EMD 72000 in Combination With ECX (Epirubicin, Cisplatin and Capecitabine) in Oesophagogastric CancerNCT00113581
Esophageal Canc...
Gastric Cancer
EMD 72000 (matu...
18 Years - Merck KGaA, Darmstadt, Germany
Matuzumab Treatment With Epirubicin, Cisplatin and Capecitabine (ECX) in Esophago-Gastric CancerNCT00215644
Esophageal Canc...
Gastric Cancer
Matuzumab
Epirubicin
Cisplatin
Capecitabine
18 Years - Merck KGaA, Darmstadt, Germany
Safety Study of EMD 72000 in Combination With ECX (Epirubicin, Cisplatin and Capecitabine) in Oesophagogastric CancerNCT00113581
Esophageal Canc...
Gastric Cancer
EMD 72000 (matu...
18 Years - Merck KGaA, Darmstadt, Germany
Matuzumab Treatment With Epirubicin, Cisplatin and Capecitabine (ECX) in Esophago-Gastric CancerNCT00215644
Esophageal Canc...
Gastric Cancer
Matuzumab
Epirubicin
Cisplatin
Capecitabine
18 Years - Merck KGaA, Darmstadt, Germany
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: